Lilly (Eli) & Co. Business Finance Contracts & Agreements

79 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Description of the Company's Common Stock
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Underwriting Agreement, dated February 7, 2024, among Eli Lilly and Company and BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2023
Underwriting Agreement, dated February 23, 2023, among Eli Lilly and Company and J.P. Morgan Securities LLC, Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC and Morgan...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Relative Value Award under the 2002 Lilly Stock Plan (non-executive)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (non-executive officer)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Description of the Company's 1.625% Notes due 2043
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Description of the Company's 0.500% Notes due 2033, 1.125% Notes due 2051, and 1.375% Notes due 2061
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Underwriting Agreement, dated September 8, 2021, among Eli Lilly and Company and Merrill Lynch International, Barclays Bank PLC, BNP Paribas, Citigroup Global Markets Limited and...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Release Agreement, effective as of February 9, 2021, by and between Eli Lilly and Company and Joshua L. Smiley
Release Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (non-executive officer)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Officers Certificate setting forth the terms and form of the 2060 Notes and certain matters with respect to the New 2050 Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Underwriting Agreement, dated August 20, 2020, among the Company and BNP Paribas Securities Corp., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Morgan Stanley &...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Restricted Stock Unit Award to Michael Harrington under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Description of the Company's 0.625% EUR Notes due 2031 and 1.700% EUR Notes due 2049
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of the Company's 7 1/8% Notes due 2025
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020